Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments
Hwang WL., Huang SW., Hsiao AC., Chen CY., Hsu KF., Hsieh YT.
Narrative Review on Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Stem Cell Res Ther (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41254732
- PMCID
- PMC12625093
- DOI
- 10.1186/s13287-025-04708-5
- Citations
- 3
Abstract (original English)
Mesenchymal stem/stromal cells (MSCs) are known for their regenerative and immunomodulatory capabilities, which have made them the focus of extensive therapeutic research. A growing body of evidence underscores that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free platform that mimics the therapeutic benefits of MSCs while mitigating their associated risks. This review synthesizes recent advancements in bioengineering strategies aimed at enhancing the therapeutic efficacy, targeting specificity, and cargo-loading capacity of MSC-EVs for cancer treatment. These strategies include endogenous and exogenous modification approaches. Endogenous strategies involve genetically modifying parental MSCs or using environmental preconditioning to modulate the extracellular vesicles (EVs) content or surface proteins of EVs they produce. Exogenous techniques include post-isolation loading of therapeutic cargo, such as small interfering RNAs (siRNAs) and microRNAs (miRNAs), as well as EV membrane modifications. We also highlight key preclinical and clinical findings, addressing the dual role of MSC-EVs, which can be either pro- or anti-tumorigenic depending on the MSC tissue origin and the tumor microenvironment. Notably, EVs derived from human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) show the most consistent tumor-suppressive
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol